We are live on ! Find out more
GGHC

Gilder Gagnon Howe & Co Portfolio holdings

AUM $9.69B
1-Year Est. Return 55.7%
This Fund
S&P 500
This Quarter Est. Return
+13.03%
1 Year Est. Return
+55.7%
3 Year Est. Return
+243.5%
5 Year Est. Return
+259.56%
10 Year Est. Return
+4,571.41%
AUM
$5.73B
AUM Growth
+$122M
Cap. Flow
-$305M
Cap. Flow %
-5.31%
Top 10 Hldgs %
36.62%
Holding
266
New
17
Increased
50
Reduced
179
Closed
19

Top Buys

Rank Stock Value
1
LLY icon
Eli Lilly
LLY
+$54.5M
2
NVO
Novo Nordisk
NVO
+$53.8M
3
ABNB icon
Airbnb
ABNB
+$35.5M
4
BNTX icon
BioNTech
BNTX
+$22.3M
5
NVDA icon
NVIDIA
NVDA
+$16.9M

Top Sells

Rank Stock Value
1
SWAV
Shockwave Medical, Inc. Common Stock
SWAV
+$45.6M
2
OKTA icon
Okta
OKTA
+$43.1M
3
ROKU icon
Roku
ROKU
+$38.5M
4
ENPH icon
Enphase Energy
ENPH
+$37.3M
5
GOOG icon
Alphabet (Google) Class C
GOOG
+$31.1M

Sector Composition

Rank Sector Weight
1 Technology 32.17%
2 Consumer Discretionary 24.08%
3 Healthcare 19.02%
4 Industrials 8.18%
5 Communication Services 7.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
OLK
201
DELISTED
Olink Holding AB (publ) American Depositary Shares
OLK
$897K 0.02%
73,884
-565
-0.8% -$8.66K
CLAS
202
DELISTED
Class Acceleration Corp.
CLAS
$836K 0.01%
84,635
-644
-0.8% -$6.35K
GWRE icon
203
Guidewire Software
GWRE
$12.6B
$799K 0.01%
12,978
+4,250
+49% +$307K
SONO icon
204
Sonos
SONO
$1.82B
$794K 0.01%
57,100
-686
-1% -$12.2K
DAVA icon
205
Endava
DAVA
$159M
$747K 0.01%
9,269
+259
+3% +$24.6K
OSCR icon
206
Oscar Health
OSCR
$10.2B
$746K 0.01%
149,491
-607,824
-80% -$3.55M
STOK icon
207
Stoke Therapeutics
STOK
$1.89B
$743K 0.01%
57,864
-445
-0.8% -$7.09K
HLLY icon
208
Holley
HLLY
$330M
$706K 0.01%
174,355
-191,176
-52% -$1.43M
TXG icon
209
10x Genomics
TXG
$9.41B
$704K 0.01%
24,702
-542,785
-96% -$20.7M
IMPL
210
DELISTED
Impel Pharmaceuticals Inc. Common Stock
IMPL
$695K 0.01%
142,696
+5,302
+4% +$40.6K
RIVN icon
211
Rivian
RIVN
$22.2B
$692K 0.01%
+21,013
New +$716K
VIRX
212
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
$690K 0.01%
161,607
-940
-0.6% -$3.98K
UBER icon
213
Uber
UBER
$146B
$671K 0.01%
25,310
+47
+0.2% +$1.3K
CHWY icon
214
Chewy
CHWY
$8.57B
$666K 0.01%
21,674
-15
-0.1% -$595
PROF
215
Profound Medical
PROF
$209M
$588K 0.01%
145,613
-902
-0.6% -$6.09K
LOVE
216
LoveSac
LOVE
$209M
$564K 0.01%
27,660
-20
-0.1% -$614
COHR icon
217
Coherent
COHR
$53.9B
$551K 0.01%
15,808
-21
-0.1% -$1.01K
SI
218
DELISTED
Silvergate Capital Corporation
SI
$523K 0.01%
6,939
+1,256
+22% +$107K
WDAY icon
219
Workday
WDAY
$46.6B
$513K 0.01%
3,369
-7
-0.2% -$1.1K
STAA icon
220
STAAR Surgical
STAA
$1.15B
$511K 0.01%
7,238
-250
-3% -$21.4K
BBIO icon
221
BridgeBio Pharma
BBIO
$14B
$481K 0.01%
48,400
-348
-0.7% -$3.62K
FSLY icon
222
Fastly Inc
FSLY
$3.96B
$465K 0.01%
50,714
-54
-0.1% -$575
VYGR icon
223
Voyager Therapeutics
VYGR
$192M
$442K 0.01%
74,607
+17,394
+30% +$111K
CMG icon
224
Chipotle Mexican Grill
CMG
$45.3B
$427K 0.01%
14,200
-250
-2% -$7.75K
OPEN icon
225
Opendoor
OPEN
$2.64B
$426K 0.01%
141,563
-9,419
-6% -$43.2K
7 8
9
10 11

Similar funds

Edgewood Management
Edgewood Management Greenwich, Connecticut $9.69B AUM 6.52% 1-Year Est. Return
SC
Starlite Capital Dallas, Texas $9.7B AUM
AV
ASR Vermogensbeheer Utrecht, Netherlands $9.71B AUM 37.32% 1-Year Est. Return
FIA
Foundations Investment Advisors Phoenix, Arizona $9.72B AUM 29.41% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
DM
Deerfield Management New York $9.59B AUM 113.36% 1-Year Est. Return
PVI
Partners Value Investments Hamilton, Bermuda $9.8B AUM 0.07% 1-Year Est. Return
HTC
Hershey Trust Company Hershey, Pennsylvania $9.82B AUM 0.48% 1-Year Est. Return

Gilder Gagnon Howe & Co's Q3 2022 Portfolio in Review

As of Q3 2022, Gilder Gagnon Howe & Co held 266 positions worth $5.73B, up 2.2% from $5.61B the previous quarter. Its ten largest holdings account for 37% of the portfolio.

Gilder Gagnon Howe & Co withdrew a net $305M in Q3 2022, closing 19 positions and reducing 179 holdings. Its most notable exit was 1Life Healthcare, an estimated $23.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 32% of assets, down from 33% a quarter earlier, followed by Consumer Discretionary and Healthcare.

Against the trend, Gilder Gagnon Howe & Co opened a new position in Novo Nordisk worth $50M.

  • Gilder Gagnon Howe & Co's largest Q3 2022 buy was Novo Nordisk: 1,004,430 shares worth $50M.
  • Gilder Gagnon Howe & Co added most to Eli Lilly in Q3 2022, an estimated $54.5M increase.
  • Gilder Gagnon Howe & Co's biggest Q3 2022 reduction was Shockwave Medical, Inc. Common Stock, cutting an estimated $45.6M.
  • Gilder Gagnon Howe & Co fully exited 1Life Healthcare in Q3 2022, selling an estimated $23.4M.
  • Gilder Gagnon Howe & Co's ten largest holdings make up 37% of its $5.73B portfolio in Q3 2022.
  • Gilder Gagnon Howe & Co opened 17 new positions and closed 19 in Q3 2022.
  • Gilder Gagnon Howe & Co's portfolio value rose 2.2% quarter-over-quarter to $5.73B.

Based on Gilder Gagnon Howe & Co's 13F filing for Q3 2022, filed 14 Nov 2022.